Filing Details
- Accession Number:
- 0001209191-21-042786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-23 17:18:29
- Reporting Period:
- 2021-06-22
- Accepted Time:
- 2021-06-23 17:18:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1662244 | Cyteir Therapeutics Inc. | CYT | () | G7 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1388325 | A/S Holdings Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-22 | 4,562,636 | $0.00 | 4,562,636 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2021-06-22 | 277,777 | $18.00 | 4,840,413 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | SERIES B CONVERTIBLE PREFERRED STOCK | Disposition | 2021-06-22 | 14,000,000 | $0.00 | 4,107,017 | $0.00 |
Common Stock | SERIES C CONVERTIBLE PREFERRED STOCK | Disposition | 2021-06-22 | 1,553,116 | $0.00 | 455,619 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into shares of common stock, based on a conversion ratio of 1 share of preferred stock for 0.2934 shares of common stock, upon the completion of the Issuer's initial public offering. These shares have no expiration date.
- Represents a purchase from the underwriters in the Issuer's initial public offering.